why choose us

First received: May 13, 2025

Clinical Trial: Speech-derived Digital Biomarkers Study

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Mild Cognitive Impairment (MCI)

Study Type: INTERVENTIONAL


Official Title: Speech-derived Digital Biomarkers for Assessing Mild Cognitive Impairment and Alzheimer's Disease Diagnosis Accuracy

Brief Summary: The goal is to assess the accuracy of an application that analyzes voice characteristics to diagnose patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD).The main question is whether the application's diagnosis is the same as the clinician's for MCI and AD patients.

Read more